Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others.

Tapping into the power of collaboration, Johns Hopkins University and West Virginia University are launching a new partnership to bring together researchers from both institutions to address complex ...